What is the first treatment tried for lobular carcinoma in situ?

Lobular carcinoma in situ, or LCIS, is a change in cells within breast lobules. It is not invasive breast cancer, but it signals increased future risk in either breast. Management depends on the LCIS pattern, how it was found, imaging and biopsy details, family history, age, and personal preferences. Some findings need further tissue assessment before follow-up is settled.

Review the pathology report with a breast specialist and confirm whether the imaging and biopsy findings match. Agree a follow-up schedule and learn how to notice a new breast or underarm change. Discuss risk-reducing endocrine therapy, including expected benefits, side effects, other medicines, and whether it fits your health history.

Arrange prompt assessment for a new breast lump, nipple inversion, bloody discharge, skin dimpling, persistent focal pain, or a swelling in the armpit. Urgent care is appropriate for severe illness or rapidly worsening symptoms.

Ask what type of LCIS was found, whether more tissue is needed, how often follow-up imaging is advised, and how endocrine therapy could interact with your health conditions.